Nanotechnology in Cancer Management
2 contributors - Paperback
£180.00
Dr. Kamil Reza Khondakar obtained his doctoral degree from the Centre of Personalised Nanomedicine in the Trau group, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Australia. He is currently involved in the multiple surface marker profiling of cancer cells and monitor the drug sensitivity effect on the cell surface markers in a Raman (SERS) based microfluidic chip. The aim of his studies is focused on the development of next-generation diagnostics chips for multiple biomarker detection on a single chip to understand the tumor heterogeneity and provide an early detection strategy for cancer management. Prior to this, he worked as a researcher in DST Center at Biomedical Instrumentation Section, National Physical Laboratory, India. His research activities included development of thin film-based microelectrodes using various nanostructures, nanocomposites for biomedical applications. He received awards and honors due to his contributions to the field of biomedical technology. He was awarded International Postgraduate Research Scholarship (IPRS) from Government of Australia, and University of Queensland Centennial Scholarship (UQCent) from The University of Queensland, Australia. He was invited to give a talk at ‘Biosensor 2018’ conference at Miami, USA. Dr. Ajeet Kaushik is Assistant Professor at the NanoBioTech laboratory, Department of Environmental Engineering, Florida Polytechnic University, USA. He is the recipient of various reputed awards for his service in the area of nano-biotechnology for health care. He has edited four books, written 100 international research peer reviewed publications, and has three patents in the area of nanomedicine and smart biosensors for personalized health care. In the course of his research, Dr. Kaushik has been engaged in design and development of various electro-active nanostructures for electrochemical biosensor and nanomedicine for health care. His research interests include nanobiotechnology, analytical systems, design and develop nanostructures, nano-carries for drug delivery, nano-therapeutics for CNS diseases, on-demand site-specific release of therapeutic agents, exploring personalized nanomedicines, biosensors, point-of-care sensing devices, and related areas of health care monitoring.